Why "Value" Is Not the Same as "Cheap"
The cheapest sticker price on a research peptide is rarely the best value when adjusted for the dimensions that matter: actual mass delivered, actual purity, shipping reliability, the probability that the vendor will still be in business if there is a quality issue, and the time cost of dealing with shortfalls. A vendor selling 5mg of "BPC-157" at $20 may be a better value than a $50 alternative if the chemistry is verifiable and the vendor's track record is intact. The same $20 product is a worse value than the $50 alternative if it actually contains 3mg of peptide at 88% purity and the vendor disappears two months after your order.
The value calculation that matters is the cost per verified active milligram delivered, not the cost per labeled milligram. For most researchers, the practical version of this calculation looks like: assume the vendor delivers 100% of label claim unless there is reason to believe otherwise. Adjust downward by the typical shortfall pattern for that vendor's tier. The result is a real cost number that can be compared across vendors.
The Per-mg Numbers That Matter
Our test-order data suggests the following rough market-floor and market-ceiling per-mg costs for legitimate research-grade product across the most-trafficked compounds. These are not guarantees; they are 2025 reference points.
| Compound | Market Floor ($/mg) | Market Ceiling ($/mg) | Notes |
|---|
| BPC-157 | $6 | $18 | Widely produced; floor reasonably reliable |
| TB-500 (fragment) | $8 | $22 | Floor varies by which fragment |
| Ipamorelin | $8 | $20 | Counterfeit risk higher at the floor |
| CJC-1295 (no DAC) | $8 | $22 | Cheaper than DAC version |
| CJC-1295 (with DAC) | $15 | $45 | 30-60% premium for the DAC modification |
| GHK-Cu | $0.40 | $1.20 | Per-mg low because typical vial is 50-100mg |
| Tesamorelin | $10 | $25 | Higher synthesis complexity |
| Semaglutide | $50 | $150 | Premium positioning across all vendors |
Bulk Pricing Reality
Most vendors offer bulk discounting that reduces per-mg cost meaningfully. A 10mg vial typically costs 60-80% of two 5mg vials; a 20mg vial typically costs 60-80% of two 10mg vials. The cost savings are real and compound across a multi-month protocol. The trade-off is reconstitution-stability risk: a larger vial reconstituted at the start of a protocol is exposed to more time at refrigerated temperature, and stability for some compounds is uncertain beyond approximately 4 weeks of reconstitution. The break-even decision depends on protocol pace; researchers running aggressive frequent-injection protocols benefit more from bulk than researchers running less frequent maintenance protocols.
The Insurance Premium for Domestic Sourcing
U.S. domestic vendors typically price 1.5-2x above international vendors for the same compound. The premium represents shorter shipping, zero customs interception risk, faster customer service response, and the practical ability to pursue refunds or replacements. For most U.S.-based researchers, that premium pays for itself in reduced operational friction. For researchers in jurisdictions without a meaningful domestic supply (UK, EU, Australia), the math is different — international is often the only realistic option, and the relevant trade-off is between international vendors with different track records rather than between domestic and international.
The Verification-Adjusted Value Argument
A pure $/mg ranking will not put Oath Research at the top of any table on this page. They are not the cheapest vendor on any single compound. They are the vendor whose verification overhead — batch-specific COAs from Freedom Diagnostics, mass-spec confirmation on counterfeit-prone compounds, the published 118-batch purity history — eliminates the most common hidden cost in the research-peptide market: the cost of finding out, weeks or months into a protocol, that the vial contained 88% of label claim at 92% purity. For a researcher running a multi-month protocol where the conclusion depends on the input being what the input claims to be, the value calculation that matters is not $/mg on the order page but $/verified mg through the assay. On that adjusted basis, the gap between premium-with-documentation and budget-without-documentation narrows substantially — and for any researcher who would otherwise commission an independent re-test before trusting a result, premium-with-documentation is the lower-cost option.
This is not an argument for Oath as the universal best-value pick. It is an argument for treating verification overhead as a real line item in the value comparison rather than a free benefit. The cheap vendors win on sticker price. The premium-with-documentation vendors win on the total cost of running a research program where the chemistry has to actually be correct.
How We Compiled This Comparison
The data in the table above reflects pricing observed in test orders placed by the editorial desk and in reader-submitted purchase confirmations during 2025. Prices fluctuate. Stock status fluctuates. COA availability fluctuates with batch. The comparison is a snapshot, not a perpetual ranking, and we update it when vendor profiles materially change.
The single most useful filter when reading any vendor comparison is the COA column. Vendors that publish batch-specific Certificates of Analysis from independent labs (Freedom Diagnostics, Janoshik, Colmaric, and a small number of comparable facilities) operate at a different transparency tier than vendors who publish generic "our peptides are tested" claims without batch-specific documentation. The first category is auditable. The second is not. Freedom Diagnostics in particular runs the forensic-grade panel — HPLC for purity, mass-balance accounting for label-claim accuracy, USP <85> endotoxin testing where requested — and the batch-by-batch reports they publish for the vendors that use them are detailed enough to cross-check against an independent re-test, which is the threshold that distinguishes documentation from marketing.
What the Per-mg Calculation Misses
Per-milligram pricing is the standard headline metric in the research-peptide market, but it can be misleading. Two vendors quoting identical $/mg may be selling materially different products if one has confirmed 98% purity by independent assay and the other claims 99% without verification. The "real" per-mg cost incorporates an adjustment for measured purity, and for vendors who routinely under-deliver mass, an additional adjustment for the average shortfall between labeled and actual mass.
The defensive habit: assume any unverified vendor's product contains 90% of the claimed peptide mass at 95% of claimed purity until you have batch-specific verification otherwise. That implicit adjustment ranges purchase decisions toward vendors with verifiable documentation rather than the lowest sticker price. Vendors whose pricing only makes sense if the headline mass and purity numbers are accurate are vendors who depend on you not checking.
Shipping Discretion and Operational Reality
Beyond chemistry, the operational variables that matter in choosing a vendor include shipping speed (most domestic vendors deliver in 3-7 business days; international can range from 7-30 days and longer if customs intercepts), packaging discretion (vials should arrive intact, in temperature-appropriate packaging, in containers that do not advertise the contents externally), and customer service responsiveness (real businesses respond to technical inquiries within 1-2 business days during weekdays; chronic non-response is a red flag).
Vendors who provide tracking from the moment of dispatch, who use insulated packaging for temperature-sensitive items, who include a packing slip that accurately describes contents (within reason), and who respond to support tickets with substantive answers rather than canned replies have demonstrated operational seriousness. Vendors who treat shipping as an afterthought have generally not.
Updating This Page
If you have placed a test order from a vendor on this list (or from one not listed) and have documentation that would refine the data — a current COA, photographs of the shipment, weights from a calibrated scale, independent assay results — submit it through the editorial channel. The contributions that have most usefully refined past updates have been independent assay results that confirmed or contradicted vendor purity claims. We treat such submissions as the highest-evidence input class and weight them accordingly in the next revision.
Where To Go From Here
Reading any individual page on this site is a slice of the picture. The full investigation continues across the related desks. The per-mg numbers above measure price; what they cannot measure is whether the vial actually contains what the vendor claims. The audit linked first below does measure that — with the milligram on the calibrated balance and the assay from the independent lab.
Editorial Standards
This report is updated periodically. Discrepancies between our reporting and reality are taken seriously — if you have observed something that contradicts what is published here, send it to the editorial desk with documentation and we will revise. Our reporting is constrained by what can be sourced, verified, or directly observed. Where evidence is weak we say so. Where it is absent we do not invent.
Wild West & Peptides receives no compensation from any vendor mentioned in this report, runs no affiliate program, and has no commercial relationship with the research-peptide industry it covers.